Impact on Quality of Life by Moxibustion in Chemotherapy for Cancer

The Comprehensive and Integrative Medicine Institute of South Korea

Status

Unknown

Conditions

Cancer

Treatments

Other: Moxibustion

Study type

Interventional

Funder types

Other

Identifiers

NCT02261571

CIMI-14-01-08

Details and patient eligibility

About

Most cancer patients experience multiple symptoms related to chemotherapy and use CAM (complementary and alternative medicine) as an adjunct to conventional treatment. Moxibustion is traditional Korean medical therapeutic method and uses the heat generated by burning herbal preparations containing Artemisia vulgaris to stimulated acupoint.

Herein, the investigators propose an open-label pilot study investigating the effectiveness of moxibustion stimulation at abdominal acupoint on quality of life in cancer patients under chemotherapy.

Enrollment

20 estimated patients

Sex

All

Ages

20 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Diagnostic histopathology of cancer
Performance status of 0-2 on the European Cooperative Oncology Group (ECOG) performance scale.
Patients on chemotherapy currently have plan to receive chemotherapy for more than 6 weeks.
Follow-up possible during the clinical trial
Informed signed consent

Exclusion criteria

Patients with Severe Heart disease and hypertension that is not controlled (systolic blood pressure >160 or Diastolic blood pressure >100)
Patients with diabetes that is not controlled (FBST >180 or BST>250)
Patients with abdominal injury or severe ascites can't be received moxibustion therapy on abdomen.
Hypersensitive section to moxibustion treatment
Inability to comprehend or express oneself in the Korean language
An Individual deemed to be ineligible by a physician
Refusal to participate in this trial or to provide informed consent.